This cancer-testing stock is BTIG’s top pick after another major earnings beat
Summary
Investment firm BTIG has designated a specific cancer-testing company as its primary stock recommendation following yet another strong quarterly financial report. This top rating comes directly on the heels of the company surpassing previous earnings expectations once again.
Source: Read the full story at Stock Market News
Disclaimer: This content is for informational and educational purposes only and is not financial, investment or trading advice. Tech & Money Press is not a registered investment adviser or broker-dealer. Trading stocks, options and crypto involves substantial risk, including the loss of your entire investment. Do your own research and consult a licensed professional before making any financial decision. The authors may hold positions in the securities mentioned. News summaries are written with AI assistance from the original publisher's report and may contain errors; always check the original source. Full disclaimer.